top of page
Search
All Posts
Ireland Needs to Rethink Its Biopharma Strategy: From Global Manufacturer to Global Owner
Ireland's biopharma sector is a world-class success story, but what worked in the past will not lead to future success. We've spent...
NíoSync
Jun 53 min read
Political theatre in the U.S., strategic tailwind in Europe — the reality behind Trump’s drug pricing order
Last week, President Trump announced a “Most Favored Nation” policy that would force pharma companies to give the U.S. the lowest global...
NíoSync
Jun 51 min read
bottom of page